We are live on ! Find out more
ZURA icon

Zura Bio
ZURA

36 hedge funds and large institutions have $77.7M invested in Zura Bio in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $60.7M → $77.7M (+$17M)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 35 → 36 (+1)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
6
Closed
4
Calls
$171K
Puts
–
Net Calls
+$171K
Net Calls Change
-$12K

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$11.7M
2
BGIM
Boussard & Gavaudan Investment Management
United Kingdom
+$3.73M
3
GCL
Glazer Capital LLC
New York
+$1.94M
4
AGC
Angelo Gordon & Co
New York
+$1.49M
5
Millennium Management
Millennium Management
New York
+$1.17M

Top Sellers

Rank Fund Capital Flow
1
BCM
Basso Capital Management
Connecticut
-$1.01M
2
SCM
Shaolin Capital Management
Florida
-$988K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$636K
4
CM
Cohanzick Management
New York
-$496K
5
DFCM
Dark Forest Capital Management
Puerto Rico
-$236K

ZURA Hedge Fund Activity: Q2 2022 in Review

36 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q2 2022, worth a combined $77.7M — up 28% from $60.7M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ZURA positions and 4 closed out — a net gain of 1 holder — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $11.7M. The largest seller was Basso Capital Management, cutting an estimated $1.01M.

  • 36 institutional investors held Zura Bio (ZURA) as of Q2 2022, up from 35 in Q1 2022.
  • Funds reported $77.7M of Zura Bio stock for Q2 2022, up 28% quarter-over-quarter.
  • 5 funds opened new Zura Bio positions in Q2 2022 and 4 closed out, a net change of +1 holder.
  • The largest Zura Bio buyer in Q2 2022 was Magnetar Financial, an estimated $11.7M added.
  • The largest Zura Bio seller in Q2 2022 was Basso Capital Management, an estimated $1.01M sold.

Based on aggregated 13F filings for Q2 2022.